CLINICOR INC
SC 13G, 1998-02-11
TESTING LABORATORIES
Previous: CLINICOR INC, SC 13G, 1998-02-11
Next: PARAGON VENTURE PARTNERS II LP, SC 13G/A, 1998-02-11



<PAGE>
 
                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, DC  20549

                                  SCHEDULE 13G
                   UNDER THE SECURITIES EXCHANGE ACT OF 1934
                              (AMENDMENT NO. ___)*

                                 CLINICOR, INC.
                         ------------------------------
                                (Name of Issuer)

                    COMMON STOCK, PAR VALUE $.001 PER SHARE
                         ------------------------------
                         (Title of Class of Securities)

                                   18726M106
                         ------------------------------
                                 (CUSIP Number)


*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).


CUSIP No.  18726M106
- --------------------------------------------------------------------------------

1.   Name of Reporting Person and S.S. or I.R.S. Identification Number

     Robert S. Sammis
- --------------------------------------------------------------------------------

2.   Check the Appropriate Row if a Member of a Group

     a.   X (see Item 4 regarding voting agreement as to certain shares)

     b.   N/A
- --------------------------------------------------------------------------------


                               Page 1 of 5 pages
<PAGE>
 
3.   SEC Use Only

- --------------------------------------------------------------------------------

4.   Citizenship or Place of Organization

     U. S. citizen
- --------------------------------------------------------------------------------

     Number of Shares Beneficially Owned by Each Reporting Person With:

5.   Sole Voting Power      733,334 shares (see Item 4)

6.   Shared Voting Power      291,283 shares (see Item 4)

7.   Sole Dispositive Power    733,334 shares (see Item 4)

8.   Shared Dispositive Power    N/A (see Item 4)
- --------------------------------------------------------------------------------

9.   Aggregate Amount Beneficially Owned by Each Reporting Person

     1,024,617 shares (see Item 4)
- --------------------------------------------------------------------------------

10.  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     N/A
- --------------------------------------------------------------------------------

11.  Percent of Class Represented by Amount in Row (9)

     24.9%
- --------------------------------------------------------------------------------

12.  Type of Reporting Person

     IN
- --------------------------------------------------------------------------------

                               Page 2 of 5 pages
<PAGE>
 
ITEM 1(a).  NAME OF ISSUER:

            Clinicor, Inc.

ITEM 1(b).  ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:

            1717 West Sixth Street, Suite 400
            Austin, Texas  78703

ITEM 2(a).  NAME OF PERSON FILING:

            Robert S. Sammis

ITEM 2(b).  ADDRESS OF PRINCIPAL BUSINESS OFFICE:

            1717 West Sixth Street, Suite 400
            Austin, Texas  78703

ITEM 2(c).  CITIZENSHIP/STATE OF ORGANIZATION:

            U.S. citizen

ITEM 2(d).  TITLE OF CLASS OF SECURITIES:

            Common Stock, par value $.001 per share

ITEM 2(e).  CUSIP NUMBER:

            18726M106

ITEM 3.     FILING PURSUANT TO RULE 13d-1(b):

            N/A

ITEM 4.     OWNERSHIP:

            (a) Amount Beneficially Owned:  1,024,617 shares

            (b) Percent of Class:  24.9%

            (c) Number of shares as to which such person has:

                (i)    sole power to vote or direct the vote:  733,334 shares

                (ii)   shared power to vote or to direct the vote:  291,283 
                       shares

                (iii)  sole power to dispose or to direct the disposition of:
                       733,334 shares


                               Page 3 of 5 pages
<PAGE>
 
                (iv) shared power to dispose or to direct the disposition of:

                     N/A

          Note: The 1,024,617 shares of Common Stock beneficially owned by Mr.
          Sammis include (1) 291,283 shares owned by other shareholders as to
          which Mr. Sammis and Mr. Thomas O'Donnell have entered into agreements
          pursuant to which Mr. Sammis and Mr. O'Donnell are jointly entitled to
          direct the manner in which such shares shall be voted and (2) 33,334
          shares issuable to Mr. Sammis pursuant to immediately exercisable
          options.

ITEM 5.   OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:

          N/A

ITEM 6.   OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:

          See explanation provided in Item 4 above.  The actual owners of the
          291,283 shares, as to which Mr. Sammis and Mr. O'Donnell are jointly
          entitled to vote, have the right to receive and the power to direct
          the receipt of dividends from, or the proceeds of the sale of, such
          shares.

ITEM 7.   IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
          SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:

          N/A

ITEM 8.   IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:

          N/A

ITEM 9.   NOTICE OF DISSOLUTION OF GROUP:

          N/A

ITEM 10.  CERTIFICATION:

          N/A


                               Page 4 of 5 pages
<PAGE>
 
                                 SIGNATURE

          After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this Section 13G is true, complete and
correct.



Dated:  February 10, 1998        /s/  Robert S. Sammis 
        -----------------        ----------------------------------------
                                 Robert S. Sammis


                               Page 5 of 5 pages


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission